Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 2/20 | 0.97 |
| ▸ | RAD1 | O60671 | 1/20 | 0.97 |
| ▸ | RAD51 | Q06609 | 6/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | USP2 | O75604 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | LTA | P01374 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.52 |
| ▸ | SENP1 | Q9P0U3 | 5/20 | 0.52 |
| ▸ | SENP3 | Q9H4L4 | 4/20 | 0.52 |
| ▸ | SUMO2 | P61956 | 3/20 | 0.52 |
| ▸ | SUMO1 | P63165 | 3/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31481692 | 1.00 | P2RY6 (0.97) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL2286120 | 1.00 | P2RY6 (0.97) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL38212 | 0.98 | P2RY6 (1.00) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL29351286 | 0.98 | P2RY6 (1.00) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL29350628 | 0.98 | P2RY6 (1.00) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL38213 | 0.98 | P2RY6 (1.00) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL27168234 | 0.97 | P2RY6 (0.97) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL15823889 | 0.97 | P2RY6 (0.97) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL439381 | 0.97 | P2RY6 (0.97) | P2RY6RAD1RAD51HSD17B10KDM4E | |
| SCHEMBL11231850 | 0.91 | RAD1 (0.86) | P2RY6RAD1RAD51HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3297616-A1 | GLUCONATE-BASED COMPOSITIONS AS A NEONATE ANTICONVULSANT | The Penn State Research Foundation (US) | 2018-03-28 | — | — | EP | claimed |
| US-9861597-B2 | Gluconate-based compositions as a neonate anticonvulsant | PENN STATE RESEARCH FOUNDATION (US) | 2018-01-09 | — | — | US | claimed |
| WO-2016187228-A1 | GLUCONATE-BASED COMPOSITIONS AS A NEONATE ANTICONVULSANT | PENN STATE RESEARCH FOUNDATION (US) | 2016-11-24 | — | — | WO | claimed |
| US-20160338980-A1 | Gluconate-Based Compositions As A Neonate Anticonvulsant | PENN STATE RESEARCH FOUNDATION | 2016-11-24 | — | — | US | claimed |
| US-7238794-B2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2007-07-03 | — | — | US | claimed |
| US-20030170692-A1 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-09-11 | — | — | US | claimed |
| EP-1324352-A2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-07-02 | — | — | EP | claimed |
| US-12427120-B2 | Compositions comprising guaifenesin and flavour compounds containing an isovanillyl group | SYMRISE AG (DE) | 2025-09-30 | — | — | US | disclosed |
| US-20240382417-A1 | Compositions Comprising Guaifenesin and Eriodictyol | SYMRISE AG (DE) | 2024-11-21 | — | — | US | disclosed |
| EP-4133263-B1 | CAPILLARY GEL ELECTROPHORESIS AND ITS USE WITH COMPLEX BIOLOGICAL MOLECULES | ARES TRADING SA (CH) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024094986-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024089270-A2 | PORE MONOMERS AND PORES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-05-02 | — | — | WO | disclosed |
| US-20240044865-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-02-08 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0463859-B1 | Immobilization of biomolecules by enhanced electrophoretic precipitation | LILLY CO ELI (US) | 1995-05-17 | — | — | EP | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| US-5166063-A | IMMOBOLIZATION OF BIOMOLECULES BY ENHANCED ELECTROPHORETIC PRECIPITATION | ELI LILLY AND COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
| EP-0463859-A2 | Immobilization of biomolecules by enhanced electrophoretic precipitation | ELI LILLY AND COMPANY (US) | 1992-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240382417-A1 | Compositions Comprising Guaifenesin and Eriodictyol | ERLIN1, TAS2R38, TAS2R39 | P2RY6 1369/4885RAD1 4848/4885RAD51 4429/4885 |
| US-12427120-B2 | Compositions comprising guaifenesin and flavour compounds containing an isovanillyl group | TAS1R1, TAS2R40, TAS2R5 | P2RY6 348/4885RAD1 4882/4885RAD51 4659/4885 |
| US-20160338980-A1 | Gluconate-Based Compositions As A Neonate Anticonvulsant | KCNN3, KCNN2, KCNN1 | P2RY6 951/4885RAD1 4538/4885RAD51 4859/4885 |
| US-20030170692-A1 | Organic conductor | DNMT1, DNMT3A, POLN | P2RY6 1326/4885RAD1 1509/4885RAD51 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.